A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder

Journal of Clinical Psychiatry

Volumn 63, Issue 1, 2002, Pages 66-74

  Liebowitz, Michael R ^a   Stein, Murray B ^a   Tancer, Manuel ^a   Carpenter, David ^a   Oakes, Rosemary ^a   Pitts, Cornelius D ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CLONAZEPAM; FLUOXETINE; GABAPENTIN; PAROXETINE; PHENYTOIN; PLACEBO; SUMATRIPTAN SUCCINATE; WARFARIN;

ADULT; AGED; ANOREXIA; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GYNECOLOGIC DISEASE; HUMAN; IMPOTENCE; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NERVOUSNESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; SINGLE BLIND PROCEDURE; SOCIAL DISABILITY; SOCIAL INTERACTION; SOCIAL PHOBIA; SOMNOLENCE; SWEATING; TREMOR; VERTIGO; XEROSTOMIA; YAWNING;

EID: 0036152363     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n0113     Document Type: Article

References (38)

1. Social phobia: A comparison of specific and generalized subtypes and avoidant personality disorder
2. Social phobia subtypes in the National Comorbidity Survey
3. Comparison of cognitive therapy versus pharmacotherapy in social phobia
4. Phenelzine versus atenolol in social phobia: A placebo-controlled comparison
5. Cognitive behavioral group therapy versus phenelzine therapy for social phobia: 12-week outcome
6. Therapeutic advances: Paroxetine for the treatment of social anxiety disorder
7. Paroxetine in social anxiety disorder: A randomized placebo-controlled study
8. Paroxetine in social phobia/social anxiety disorder
9. Sertraline for social phobia: A double-blind, placebo-controlled crossover study
10. Paroxetine in the treatment of generalized social phobia: An open-label treatment and double-blind placebo-controlled discontinuation
11. Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized, controlled trial
12. Sertraline treatment of generalized social phobia: A 20-week double-blind, placebo-controlled study
13. Psychopharmacological treatment of social phobia: A double-blind placebo-controlled study with fluvoxamine
14. A double-blind, placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa
15. Pharmacotherapy of social phobia: A controlled study with moclobemide and phenelzine
16. Psychopharmacological treatment of social phobia: Clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor
17. Moclobemide in social phobia: A controlled, dose-response trial
18. Placebo-controlled trial of moclobemide in social phobia
19. Treatment of social phobia with clonazepam and placebo
20. Treatment of social phobia with benzodiazepines
21. A pilot study of social phobia with alprazolam
22. An algorithm for the pharmacotherapy of social phobia
23. Treatment of social phobia with gabapentin: A placebo-controlled study
24. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder
25. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder
26. A rating scale for depression
27. Social phobia
28. Measurement of social-evaluative anxiety
29. Assessing impairment in patients with panic disorder: The Sheehan Disability Scale
30. Illness intrusiveness in individuals with panic disorder, obsessive-compulsive disorder, or social phobia
31. The diagnosis of social phobia
32. The direct and indirect costs of social phobia in managed care patients
33. ECNP position paper on social phobia
34. Quality of life in social phobia
35. Social phobia: Comorbidity and morbidity in an epidemiological sample
36. Fluoxetine in social phobia